| Literature DB >> 35414548 |
Xingna Zhang1, Gwilym Owen2, Mark A Green3, Iain Buchan2, Ben Barr2.
Abstract
OBJECTIVES: To analyse the impact on SARS-CoV-2 transmission of tier 3 restrictions introduced in October and December 2020 in England, compared with tier 2 restrictions. We further investigate whether these effects varied between small areas by deprivation.Entities:
Keywords: COVID-19; health policy; public health
Mesh:
Year: 2022 PMID: 35414548 PMCID: PMC9006191 DOI: 10.1136/bmjopen-2021-054101
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Location of areas that entered tier 3 (yellow) and tier 2 (purple) at the two intervention time points.
The comparison between the tier 3 and tier 2 areas at the two intervention time points in the 4 weeks prior to the introduction of the tiered system
| October 2020 | December 2020 | |||
| Tier 3 | Tier 2 | Tier 3 | Tier 2 | |
| Average % estimated case detection rate (confirmed cases/estimated number of infections) in 4 weeks before tiers introduced | 45 | 52 | 41 | 47 |
| Average tests per 100 000 per week in 4 weeks before tiers introduced | 3232 | 2354 | 2970 | 2752 |
| Weekly infections per 100 000 per week in 4 weeks before tiers introduced | 723 | 307 | 784 | 355 |
| Care home beds per 10 000 population | 98 | 69 | 86 | 80 |
| IMD score | 31 | 25 | 26 | 19 |
| Population density—people per hectare | 32 | 51 | 30 | 41 |
| % of population 70+ | 14 | 12 | 14 | 14 |
| % population 7–11 years old | 6 | 6 | 6 | 6 |
| % BAME | 7 | 22 | 12 | 15 |
| % | NA | NA | 23 | 41 |
| % students | 3 | 4 | 3 | 3 |
| Total population | 3 068 261 | 25 272 230 | 23 347 218 | 31 682 197 |
| Number of MSOAs | 391 | 2994 | 2858 | 3774 |
BAME, Black Asian and Minority Ethnic; IMD, Indices of Multiple Deprivation.
Figure 2The trend in case rates with their 95% CIs in the tier 3 areas and in the synthetic control group.
Results of the synthetic control analysis—indicating the relative reduction in infections in tier 3 areas compared with what would have been expected if tier 2 restrictions had been applied
| Percentage change in cases | 95% CI | P value | P value for interaction in subgroup analysis | ||
| LCL | UCL | ||||
| October 2020—all tier 3 | −14 | −19% | −10% | <0.001 | |
| Most affluent areas | −10 | −17% | −2% | 0.016 | |
| Intermediate deprivation | −15 | −22% | −7% | <0.001 | 0.354 |
| Most deprived areas | −19 | −29% | −7% | 0.003 | 0.214 |
| December 2020—all tier 3 | −20 | −29% | −13% | <0.001 | |
| Most affluent areas | −19 | −24% | −14% | <0.001 | |
| Intermediate deprivation | −26 | −38% | −11% | 0.001 | 0.362 |
| Most deprived areas | −14 | −26% | 0% | 0.046 | 0.448 |
| Low SGTF (2%–20%) | −13 | −30% | 9% | 0.236 | |
| Intermediate SGTF (21%–44%) | −6 | −16% | 5% | 0.271 | 0.579 |
| High SGTF (45%–85%) | −27 | −35% | −18% | <0.001 | 0.174 |
Interaction analysis shows differences in effect by level of deprivation and prevalence of variant B.1.1.7 indicated by SGTF where quantitative reverse transcriptase PCR is used for COVID-19 diagnosis.
SGTF, S-gene target failure.